Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001921094-25-000309
Filing Date
2025-03-12
Accepted
2025-03-12 16:47:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2906
  Complete submission text file 0001921094-25-000309.txt   4417
Mailing Address 1050 HINGHAM STREET ROCKLAND MA 02370
Business Address
Megna Michael R (Reporting) CIK: 0001464583 (see all company filings)

Type: 144

Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Subject) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38492 | Film No.: 25732369
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)